UPDATED May 01, 2024
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
WTC | AU$88.81 | -3.0% | 31.8% | AU$29.4b | AU$88.99 | PE132.7x | E27.2% | 0.2% | Software | ||
GMG | AU$31.51 | 0.5% | 65.2% | AU$59.8b | AU$29.88 | PB3.4x | E25.7% | 1.0% | Real Estate | ||
REA | AU$176.68 | -2.0% | 28.6% | AU$23.3b | AU$174.31 | PE82.8x | E20.5% | 1.0% | Media | ||
WOW | AU$31.82 | -0.8% | -18.3% | AU$38.9b | AU$35.14 | PB7.6x | E47.1% | 3.3% | Consumer Retailing | ||
XRO | AU$123.18 | 2.8% | 35.4% | AU$18.8b | AU$129.38 | PS13.4x | E42.4% | n/a | Software | ||
JHX | AU$53.56 | -2.1% | 61.2% | AU$23.2b | AU$58.19 | PE28.2x | E14.0% | n/a | Materials | ||
S32 | AU$3.50 | 5.7% | -14.2% | AU$15.8b | AU$3.78 | PS1.5x | E73.0% | 0.2% | Materials | ||
CSL | AU$274.49 | -1.4% | -8.4% | AU$132.6b | AU$307.93 | PE34.9x | E14.7% | 1.3% | Pharmaceuticals & Biotech | ||
SCG | AU$3.11 | -1.6% | 11.1% | AU$16.1b | AU$3.30 | PB0.9x | E20.4% | 5.3% | Real Estate | ||
TCL | AU$12.55 | -2.7% | -13.4% | AU$38.8b | AU$13.30 | PE171x | E27.0% | 5.0% | Transportation | ||
ALL | AU$39.34 | -4.2% | 4.4% | AU$24.9b | AU$47.49 | PE17.1x | E5.1% | 1.7% | Consumer Services | ||
COH | AU$317.17 | -0.9% | 29.8% | AU$20.8b | AU$280.94 | PE59.3x | E12.2% | 1.3% | Healthcare |